Facebook Linkedin Mail Twitter
Facebook Linkedin Mail Twitter

Tag: sparsentan

Renalys Pharma announces first patient dosed in Phase III clinical trial...

Renalys Pharma has announced last week that the first person was dosed in its registrational Phase III clinical trial of sparsentan for the treatment...
Renal Interventions

Write to us
Editor: Will Date [email protected]
Advertising: Rav Pankhania [email protected]


United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Facebook Linkedin Mail Twitter